[Skip to Navigation]
Sign In
Views 301
Citations 0
Invited Commentary
May 2017

A Plea to Expand the Scope of Tumor Boards

Author Affiliations
  • 1Mayo Clinic College of Medicine, Mayo Clinic AZ, Phoenix
JAMA Surg. 2017;152(5):460. doi:10.1001/jamasurg.2016.5051

Manjelievskaia et al1 present thought-provoking data that demonstrate an ethical issue. They reveal the disparity of cancer treatment based on age, not on data-driven guidelines. The “relative” simplicity of their study (and it is not simple) relies on clear definitions of age and insurance coverage.

The definition of age groups is prone to criticism. The authors use 50 years of age, the national recommendation for starting normal-risk screening colonoscopies. While recent statistics reveal colorectal cancer increased among patients aged younger than 50 years by 1.8% per year, compared with a decrease of 3% in patients aged between 50 and 75 years2 (which may alter screening guidelines), the cutoff of 50 years reflects current practices.

Add or change institution